Surrozen (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 15, 2019
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Company Description
- Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
- Market
- Regenerative Medicine
- Location
- South San Francisco, California, USA
- Coinvestors
- Hartford HealthCare Endowment, Horizons Ventures, NS Investment, The Column Group